Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Barrier Therapeutics Inc. (BTRX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: BTRX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on BTRX
Mike Havrilla
(1951 followers)
Navigating the Micro-Cap Biotech Minefield
(Sun, Nov 23)
Even Fatter Yields for Pfizer; M&A Targets in the Sector
(Fri, Oct 17)
Discovery Labs: The Next Biotech Buy?
(Mon, Oct 6)
More by Mike Havrilla on BTRX »
Centient Biotech Investor
(10 followers)
Biotech Day in Review: Hollis-Eden Loses Stockpile Contract for Neumune
(Fri, Mar 9)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on BTRX »
The Wall Street Transcript
(86 followers)
Investing in Small Cap Pharmaceuticals: Noven, Barrier, Penwest and Endo
(Mon, Jan 8)
More by The Wall Street Transcript on BTRX »
Most followed authors on BTRX
Mike Havrilla
(1951 followers)
Navigating the Micro-Cap Biotech Minefield
(Sun, Nov 23)
Even Fatter Yields for Pfizer; M&A Targets in the Sector
(Fri, Oct 17)
Discovery Labs: The Next Biotech Buy?
(Mon, Oct 6)
More by Mike Havrilla on BTRX »
Michael Shulman
(249 followers)
Barrier's Turnaround Jump-Starts Revenue
(Thu, May 29)
More by Michael Shulman on BTRX »
The Wall Street Transcript
(86 followers)
Investing in Small Cap Pharmaceuticals: Noven, Barrier, Penwest and Endo
(Mon, Jan 8)
More by The Wall Street Transcript on BTRX »
Newest authors on BTRX
Michael Shulman
(249 followers)
Barrier's Turnaround Jump-Starts Revenue
(Thu, May 29)
More by Michael Shulman on BTRX »
Mike Havrilla
(1951 followers)
Navigating the Micro-Cap Biotech Minefield
(Sun, Nov 23)
Even Fatter Yields for Pfizer; M&A Targets in the Sector
(Fri, Oct 17)
Discovery Labs: The Next Biotech Buy?
(Mon, Oct 6)
More by Mike Havrilla on BTRX »
Centient Biotech Investor
(10 followers)
Biotech Day in Review: Hollis-Eden Loses Stockpile Contract for Neumune
(Fri, Mar 9)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on BTRX »
Most commented on BTRX
Mike Havrilla
(1951 followers)
Navigating the Micro-Cap Biotech Minefield
(Sun, Nov 23)
Even Fatter Yields for Pfizer; M&A Targets in the Sector
(Fri, Oct 17)
Discovery Labs: The Next Biotech Buy?
(Mon, Oct 6)
More by Mike Havrilla on BTRX »
Richard Shonfeld
(4 followers)
Novartis to Promote Barrier Therapeutics' “Vusion” Ointment to Pediatricians
(Wed, Mar 7)
More by Richard Shonfeld on BTRX »
Centient Biotech Investor
(10 followers)
Biotech Day in Review: Hollis-Eden Loses Stockpile Contract for Neumune
(Fri, Mar 9)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on BTRX »